Navigation Links
MRI Interventions and Brainlab Launch European Commercialization Effort with First ClearPoint Case in Europe
Date:9/19/2012

MEMPHIS, Tenn. and MUNICH, Sept. 19, 2012 /PRNewswire/ -- MRI Interventions, Inc. (OTCBB:MRIC) and Brainlab AG announced today that Prof. Stephan Chabardes at Universite Joseph Fourier (UJF) Hospital in Grenoble, France has performed the first two cases in Europe with the ClearPoint® Neuro Intervention System.  Prof. Chabardes used the ClearPoint system to assist with the implantation of deep brain stimulation (DBS) leads in two patients suffering from Parkinson's disease.  In addition to being the first ClearPoint commercial cases in Europe, the cases carried the historical significance of being performed at the location where DBS treatment was originally developed.

DBS therapy is a reversible and adjustable treatment for a variety of neurological disorders by which an electronic lead is placed at a targeted location inside the brain and connected to a pulse generator that is implanted under the skin in the patient's chest area.  The pulse generator is set to a customized frequency, and it delivers small electrical pulses to the target area of the brain.  The device, which some refer to as a "pacemaker for the brain," is used to suppress disabling symptoms associated with the particular neurological disorder being treated. Since its inception 25 years ago, DBS has become an important and established treatment that has improved the quality of life for over 80,000 people.

The traditional surgical technique for implanting DBS leads has been performed without intra-procedural visualization, meaning that the surgeon cannot see the neurological target and surgical devices inside the brain while the procedure is being performed.  By contrast, the next generation ClearPoint system provides surgeons with direct, real-time visualization of the patient's anatomy and the surgical devices throughout the procedure.  Using the ClearPoint system, the surgeon sees and selects the neurological target, aims the
'/>"/>

SOURCE MRI Interventions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
2. iBioLaunchâ„¢ Technology Successfully Applied to Modified C1 Inhibitor
3. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
4. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
5. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
6. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
7. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
8. Cellular Dynamics Announces Commercial Launch of iCell® Neurons for Neuroscience Drug Discovery
9. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
10. ReproCELL Licensed Commercialization Right on Human iPS Cell Derived Hepatocytes - Expected Launch in Q2 2012
11. China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , the leading life sciences employment and news website, launched the ... Illinois , Indiana , ... , Minnesota , Missouri , ... Wisconsin . BioMidwest is a leader in biotech and ... in this region in 2013. The life sciences sector in this area ...
(Date:7/31/2014)... Researchers at Johns Hopkins have mapped the sound-processing part ... both the proverbial forest and the trees in view. ... views of brain activity within mice, and it enabled ... mice "called" to each other. The results, which represent ... process language, appear online July 31 the journal ...
(Date:7/31/2014)... 2014 Graphite Metallizing Corporation announces ... carts. These bearings are uniquely suited to prevent loss ... because of the high temperatures . , Recently, ... the design engineers at Graphite Metallizing to overcome problems ... their manufacturing operation, pans containing blocks of powder mixture ...
(Date:7/31/2014)... -- Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel ... supply industries, today reported financial results for the ... quarter with $33.6 million in cash and highly ... quarter Senomyx achieved another important milestone with the ...
Breaking Biology Technology:Midwest Biotech Leaders Featured On BioSpace Map 2New mapping approach lets scientists zoom in and out as the brain processes sound 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 14SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 15SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2014 FINANCIAL RESULTS 16
... -- China Sky One Medical, Inc. ("China Sky One Medical" ... fully integrated pharmaceutical company in the People,s Republic of China ... Ren Medical Science and Technology Company ("TDR"), signed an agreement ... Tian Xin Biological Engineering Ltd. Harbin Tian ...
... Dec. 15, 2011  BioMed Realty Trust, Inc. (NYSE: ... declared a fourth quarter 2011 dividend of $0.20 per share ... dividend of $0.80 per common share. BioMed ... dividend of $0.46094 per share of the company,s 7.375% Series A ...
... 15, 2011 PDL BioPharma, Inc. (PDL) (NASDAQ: ... 15, 2011, regular quarterly dividend payment of $0.15 per share ... 8, 2011, the record date. (Logo: ... BioPharma PDL pioneered the humanization of monoclonal antibodies and, ...
Cached Biology Technology:China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise 2China Sky One Medical to Jointly Launch Adult Stem Cell Research Enterprise 3BioMed Realty Trust Declares Fourth Quarter 2011 Common Stock and Preferred Stock Dividends 2
(Date:7/31/2014)... France, and the U.S. has discovered and described ... member of the tribe Omaliini that has ever ... were made possible through the use of the ... the detailed study of otherwise invisible specimens in ... the journal Annals of the Entomological Society ...
(Date:7/31/2014)... percent of animal models against the highly infectious and ... intestinal disease that kills approximately 30,000 Americans annually. The ... and Immunity . , In the study, the ... purified toxins produced by C. difficile , as ... model that mimics the human disease, after only two ...
(Date:7/31/2014)... Prolonged exposure to loud noise alters how the ... distinguishing speech sounds, according to neuroscientists at The ... paper published this week in Ear and ... how noise-induced hearing loss affects the brain,s recognition ... reaches all corners of the population, affecting an ...
Breaking Biology News(10 mins):C. difficile vaccine proves safe, 100 percent effective in animal models 2UT Dallas study reveals effect of loud noises on brain 2
... Based on a pilot study in children with sarcoma, ... that immunotherapy could prove beneficial in treating high-risk forms ... novel dendritic vaccine as well as a standard flu ... Their findings, published in the August 1 issue ...
... surprisingly simple, inexpensive technique, chemists have found a way ... amounts of electricity, common chemicals and a room-temperature glass ... fuels, many researchers have proposed using solar electricity to ... when the sun goes down. One of the chief ...
... NY In the United States, Lyme disease is ... from animals to humans. These animal-borne diseases can make ... and effective intervention are crucial to protecting the public. ... Millbrook, NY recently received $750,000 in grant funding from ...
Cached Biology News:Immunotherapy in high-risk pediatric sarcomas shows promising response 2Immunotherapy in high-risk pediatric sarcomas shows promising response 3Water refineries? 2Water refineries? 3EPA funds ground-breaking Lyme disease research 2
...
Immunogen: MBP-fusion protein of the C-terminal region of the a2 subunit (amino acids K581-D670) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Replacement Parts for Electrophoresis Apparatus...
Histone H2A Polyclonal Antibody 100 ug affinity purified rabbit polyclonal antibody. Detects ~14 kDa Histone H2A. It does not cross-react with other Histones. Reacts with human/mouse/rat. Performs w...
Biology Products: